Chieko Ishiguro
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
-
- Intensive Care Unit Cognitive Disorders
Papers in
- Toxicology 12
- Pharmacovigilance and Adverse Drug Reactions 12
-
- SARS-CoV-2 and COVID-19 Research 8
- Co-authors
- Haruhisa Fukuda (12 shared papers)Yoshiaki Uyama (20 shared papers)Kosuke Kiyohara (1 shared paper)Rei Ono (1 shared paper)Yoshinori Takeuchi (4 shared papers)Yosuke Fujii (1 shared paper)Takashi Omori (1 shared paper)Toshiharu Fujita (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (7 papers)Therapeutic Innovation & Regulatory Science (5 papers)Journal of Epidemiology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)The Lancet Regional Health - Western Pacific (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Chieko Ishiguro
47 papers receiving 475 citations
Peers
Comparison fields: 5 of 90
- Toxicology 70
- Critical Care and Intensive Care Medicine 31
- Geriatrics and Gerontology 15
- Pharmacology 34
- Statistics and Probability 30
Countries citing papers authored by Chieko Ishiguro
This map shows the geographic impact of Chieko Ishiguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieko Ishiguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieko Ishiguro more than expected).
Fields of papers citing papers by Chieko Ishiguro
This network shows the impact of papers produced by Chieko Ishiguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieko Ishiguro. The network helps show where Chieko Ishiguro may publish in the future.
Co-authors
The 25 scholars most cited alongside Chieko Ishiguro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 50 | |
| 2 | 2008 | 42 | |
| 3 | 2010 | 36 | |
| 4 | 2019 | 27 | |
| 5 | 2015 | 26 | |
| 6 | 2018 | 22 | |
| 7 | 2022 | 21 | |
| 8 | 2000 | 21 | |
| 9 | 2016 | 20 | |
| 10 | 2014 | 18 | |
| 11 | 2020 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2007 | 13 | |
| 14 | 2022 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2005 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2022 | 8 |
About Chieko Ishiguro
Chieko Ishiguro is a scholar working on Toxicology, Infectious Diseases, Epidemiology, Health and Pharmacology, having authored 54 papers that have together received 487 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Vaccine Coverage and Hesitancy (6 papers), Pharmacy and Medical Practices (5 papers), Pharmaceutical studies and practices (3 papers), Influenza Virus Research Studies (3 papers), Statistical Methods in Clinical Trials (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Toxicology (70 citations), Critical Care and Intensive Care Medicine (31 citations), Geriatrics and Gerontology (15 citations), Pharmacology (34 citations) and Statistics and Probability (30 citations). Chieko Ishiguro has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Haruhisa Fukuda, Yoshiaki Uyama, Kosuke Kiyohara, Rei Ono, Yoshinori Takeuchi, Yosuke Fujii, Takashi Omori, Toshiharu Fujita, Tosiya Sato and Dan Li. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Therapeutic Innovation & Regulatory Science, Journal of Epidemiology, Clinical Pharmacology & Therapeutics and The Lancet Regional Health - Western Pacific.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.